Generis Farmaceutica, S.A.; Laboratorio Pfizer, Lda.; Fresenius Kabi Pharma Portugal, Lda. secures contract for 41/74/2026 Medications Ketorolac, Terlipressin, Parecoxib And Paricalcitol

Portugal, Feb. 12 -- Portugal based Generis Farmaceutica, S.A.; Laboratorio Pfizer, Lda.; Fresenius Kabi Pharma Portugal, Lda. has secured contract from Unidade Local De Saude Do Algarve, Epe for 41/74/2026 Medications Ketorolac, Terlipressin, Parecoxib And Paricalcitol. The value of the contract is worth 2245607 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....